[Thieno[2,3-d]pyrimidines as antagonists of the glutamate receptors]

Pharmazie. 2008 Nov;63(11):823-6.
[Article in German]

Abstract

Although the function of the kainate receptors in the brain is still not clear, they are increasingly defined as targets in the development of new classes of anti-epileptics. The thienopyrimidines described in this report were tested for their antagonistic effect at the kainate receptor subtypes GluR5 and GluR6. The highest effectiveness was obtained by a 4-ethoxy-thieno[2,3-d]pyrimidin with an IC50 = 68 microM at the GluR6 receptor.

Publication types

  • English Abstract

MeSH terms

  • Brain Chemistry / drug effects
  • Cells, Cultured
  • Excitatory Amino Acid Antagonists / chemical synthesis
  • Excitatory Amino Acid Antagonists / pharmacology*
  • GluK2 Kainate Receptor
  • Humans
  • Indicators and Reagents
  • Magnetic Resonance Spectroscopy
  • Pyrimidines / pharmacology*
  • Receptors, Glutamate / drug effects*
  • Receptors, Kainic Acid / antagonists & inhibitors
  • Receptors, Kainic Acid / metabolism

Substances

  • Excitatory Amino Acid Antagonists
  • Gluk1 kainate receptor
  • Indicators and Reagents
  • Pyrimidines
  • Receptors, Glutamate
  • Receptors, Kainic Acid